NeuroSense Therapeutics, Ltd. Announces the Presentation of Phase IIa Study Results at Four International Conferences

/PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Israel ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Israeli ,Shiran Zimri ,Research Symposium ,International Conference On Alzheimer Parkinson ,Prnewswire Neurosense Therapeutics Ltd ,Israeli Neurological Association Annual Meeting ,Nasdaq ,Neurosense Therapeutics Ltd ,Sense Therapeutics ,International Conference ,Israeli Neurological Association Annual ,Scientific Programs ,Neurosense ,